Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Prostate Cancer
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Prostate Cancer
    Prostate Cancer Patients Disease Free After 5 Years Likely to Be Disease Free After 10 Years - (DGNews)
    Selenium May Worsen Prostate Cancer in Men With SOD2 Gene Variant - (DGNews)
    TopAbstracts in Prostate Cancer 06/24/2009 - (DGNews)
    Prostate Cancer Test Improves Prediction of Disease Course - (DGNews)
    Duration of androgen suppression in the treatment of prostate cancer - (N Engl J Med)

    News archive

     Recent webcasts/CME - Prostate Cancer
    • Exploring the Link Between Hypogonadism and Metabolic Comorbidities
    • Diagnosing Hypogonadism: Recommendations for Testing and Treating to Improve Outcomes
    • Remplacement de la testostérone : surveillance d'un point de vue pratique
    • Finasteride and Prostate Cancer Prevention: The Latest Chapter
      Emerging Research May Improve Prostate Cancer Treatment

      Webcasts/CME archive

       Recent cases - Prostate Cancer
        Non-Prostatic Pathology on Prostate Needle-Biopsy - Colorectal Carcinoid: A Case Report
        A 70-Year-Old Male Having Advanced Prostate Cancer Presenting with Hypercalcemia and Diffuse Osteoblastic Bone Metastases: A Case Report
        A Dramatic, Objective Antiandrogen Withdrawal Response: Case Report and Review of the Literature
        Anejaculation as an Atypical Presentation of Prostate Cancer: A Case Report
        FDG PET-CT Demonstration of Metastatic Neuroendocrine Tumor of Prostate

        Cases archive
          




        my personal edition > prostate cancer > news
        divider

          E-Mail this DGNews to a colleague

        DGNews


        Stress May Help Cancer Cells Stay Alive

        WINSTON-SALEM, NC -- April 10, 2007 -- Scientists report that the stress hormone epinephrine causes changes in prostate and breast cancer cells that may make them resistant to cell death.

        "These data imply that emotional stress may contribute to the development of cancer and may also reduce the effectiveness of cancer treatments," said George Kulik, DVM, PhD, an assistant professor of cancer biology and senior researcher on the project. The study results are reported on-line in the Journal of Biological Chemistry and will appear in a future print issue.

        Levels of epinephrine, which is produced by the adrenal glands, are sharply increased in response to stressful situations and can remain continuously elevated during persistent stress and depression, according to previous research. The goal of the current study was to determine whether there is a direct link between stress hormones and changes in cancer cells.

        While a link between stress and cancer has been suggested, studies in large groups of people have been mixed. "Population studies have had contradictory results," said Kulik. "We asked the question, 'If stress is linked to cancer, what is the cellular mechanism?' There had been no evidence that stress directly changes cancer cells."

        Studying prostate and breast cancer cells in the laboratory, Kulik and colleagues found that a protein called BAD – which causes cell death – becomes inactive when cancer cells are exposed to epinephrine.

        Kulik said that connection between stress and prostate cancer has been largely unexplored. However, recent studies suggest that these laboratory findings may apply to cancer patients. "A study from Canada showed that men who took beta blockers for hypertension for at least four years had an 18% lower risk of prostate cancer," said Kulik. "These drugs block the effects of epinephrine, which could explain the finding. Another study of men after radical prostatectomy reported increased mood disturbances, which are often associated with elevated stress hormones. Although these studies do not directly address the role of stress hormones, they suggest that stress hormones may play an important role in prostate cancer."

        Kulik said the findings have several implications for patients and for researchers. "It may be important for patients who have increased responses to stress to learn to manage the effects," said Kulik. "And, the results point to the possibility of developing an intervention to block the effects of epinephrine."

        Kulik is now studying blood samples of prostate cancer patients to determine if there is a link between levels of stress hormones and severity of disease and has begun studying the effects of epinephrine in mice with prostate cancer.


        SOURCE: Wake Forest University Baptist Medical Center



        E-Mail this DGNews to a colleague   To print, use this version






        All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send